Nicholas Hamm
Mylan Finalizes $465 Million EpiPen Settlement
Mylan Finalizes $465 Million EpiPen Settlement
The settlement is the end of a long legal battle.
Express Scripts Limits Opioid Prescriptions
Express Scripts Limits Opioid Prescriptions
The PBM giant is cutting down on the number of opioids new patients can buy.
Recall of Not-So-Sterile Drug Products
FDA is alerting health professionals to a sterility breach with Vital Rx Inc. products.
When Price Dictates Treatment
When drug prices spike, health-care providers are forced to make tough choices.
Abuse-Deterrent Opioids Aren’t Effective
Abuse-Deterrent Opioids Aren’t Effective
New research suggests that the latest trend in opioids may not be so helpful.
FDA Recalls All PharmaTech Liquid Drugs
FDA Recalls All PharmaTech Liquid Drugs
The recall affects a variety of distributors.
Pharmacy 2028: A Look Ahead
Pharmacy 2028: A Look Ahead
Here's the technology your pharmacy might have in the next 10 years.
What Do Your Patients Do with Unused Meds?
How one product is making it easier for your patients to safely dispose of their medications.
DEA Wants 20% Reduction in Opioids
DEA Wants 20% Reduction in Opioids
The agency says that the reduction lines up with current demand for opioids.
Faster Drug Approvals Mean Healthier Patients (Maybe)
Faster Drug Approvals Mean Healthier Patients (Maybe)
How the FDA is prioritizing drugs that offer the biggest health gains.

Poll